T&L Co., Ltd. (KOSDAQ:340570)

Market Cap	623.16B
Revenue (ttm)	150.31B
Net Income (ttm)	39.56B
Shares Out	8.07M
EPS (ttm)	4,900.24
PE Ratio	15.75
Forward PE	10.01
Dividend	750.00 (0.97%)
Ex-Dividend Date	Dec 27, 2024

Volume	65,281
Average Volume	80,808
Open	77,500
Previous Close	77,500
Day's Range	75,300 - 78,700
52-Week Range	45,200 - 85,600
Beta	0.28
RSI	49.85
Earnings Date	Feb 5, 2025

About T&L Co., Ltd.

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was founded in 1998 and is headquartered in Yongin-si, South Korea.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1998
• Employees: 142
• Stock Exchange: KOSDAQ
• Ticker Symbol: 340570

Financial Performance

In 2023, T&L Co., Ltd.'s revenue was 115.46 billion, an increase of 41.54% compared to the previous year's 81.58 billion. Earnings were 27.44 billion, an increase of 29.93%.